MedPlus Health Services Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

MedPlus Health Services şirketinin toplam hissedar öz sermayesi ₹16.4B ve toplam borcu ₹0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla ₹31.6B ve ₹15.2B dir. MedPlus Health Services 'in FAVÖK'ü ₹1.9B faiz karşılama oranı 2.4 dur. Şirketin ₹2.7B tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

Borç/özkaynak oranı

₹0

Borç

Faiz karşılama oranı	2.4x
Nakit	₹2.68b
Eşitlik	₹16.36b
Toplam yükümlülükler	₹15.19b
Toplam varlıklar	₹31.55b

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

There Are Reasons To Feel Uneasy About MedPlus Health Services' (NSE:MEDPLUS) Returns On Capital

Aug 30

Is Now The Time To Put MedPlus Health Services (NSE:MEDPLUS) On Your Watchlist?

Feb 03

MedPlus Health Services (NSE:MEDPLUS) Will Want To Turn Around Its Return Trends

Dec 11

A Look At The Intrinsic Value Of MedPlus Health Services Limited (NSE:MEDPLUS)

Oct 24

The Returns On Capital At MedPlus Health Services (NSE:MEDPLUS) Don't Inspire Confidence

Jul 18

Why Investors Shouldn't Be Surprised By MedPlus Health Services Limited's (NSE:MEDPLUS) P/S

Jun 22

A Look At The Fair Value Of MedPlus Health Services Limited (NSE:MEDPLUS)

Apr 18

MedPlus Health Services (NSE:MEDPLUS) Could Be Struggling To Allocate Capital

Feb 08

₹1,177: That's What Analysts Think MedPlus Health Services Limited (NSE:MEDPLUS) Is Worth After Its Latest Results

Jun 03

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: MEDPLUS 'nin kısa vadeli varlıkları ( ₹17.1B ) kısa vadeli yükümlülüklerini ( ₹5.6B ) aşıyor.

Uzun Vadeli Yükümlülükler: MEDPLUS şirketinin kısa vadeli varlıkları ( ₹17.1B ) uzun vadeli yükümlülüklerini ( ₹9.6B ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: MEDPLUS borçsuzdur.

Borcun Azaltılması: MEDPLUS şirketinin 5 yıl önce borç/öz sermaye oranı 25.5% iken borcu yok.

Borç Kapsamı: MEDPLUS un borcu yoktur, dolayısıyla işletme nakit akışı tarafından karşılanmasına gerek yoktur.

Faiz Kapsamı: MEDPLUS şirketinin borcu bulunmadığından faiz ödemelerinin karşılanması söz konusu değildir.

MedPlus Health Services Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 6/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

MedPlus Health Services Limited to Report Q2, 2025 Results on Nov 12, 2024

MedPlus Health Services Limited Appoints Aparna Surabhi as Non-Executive Independent Director

There Are Reasons To Feel Uneasy About MedPlus Health Services' (NSE:MEDPLUS) Returns On Capital

Now 22% overvalued

MedPlus Health Services Limited, Annual General Meeting, Sep 26, 2024

First quarter 2025 earnings: EPS exceeds analyst expectations

Insufficient new directors

Medplus Health Services Limited Announces Cessation of Ms. Hiroo Mirchandani as Non-Executive Independent Director

MedPlus Health Services Limited to Report Q1, 2025 Results on Aug 02, 2024

Optival Health Solutions Private Limited Received Order for Temporarily Suspending the Operations of Store situated at Prakash Nagar Kurnool District Andra Pradesh, C.B Pura Road and MB Road Kolar, Karnataka for seven days each store

MedPlus Health Services Limited to Report Q4, 2024 Results on May 28, 2024

Price target decreased by 8.7% to ₹883

Consensus EPS estimates fall by 12%

New major risk - Financial position

Third quarter 2024 earnings released: EPS: ₹1.15 (vs ₹1.12 in 3Q 2023)

Is Now The Time To Put MedPlus Health Services (NSE:MEDPLUS) On Your Watchlist?

MedPlus Health Services Limited to Report Q3, 2024 Results on Feb 02, 2024

Medplus Health Services Limited Announces Resignation of Surendranath Mantena, Chief Operating Officer

MedPlus Health Services (NSE:MEDPLUS) Will Want To Turn Around Its Return Trends

Second quarter 2024 earnings released: EPS: ₹1.22 (vs ₹0.55 in 2Q 2023)

A Look At The Intrinsic Value Of MedPlus Health Services Limited (NSE:MEDPLUS)

MedPlus Health Services Limited to Report Q2, 2024 Results on Oct 26, 2023

MedPlus Health Services Limited Announces Resignation of Atul Gupta as Non-Executive Non-Independent Director

Price target increased by 11% to ₹990

MedPlus Health Services Limited, Annual General Meeting, Sep 29, 2023

New major risk - Financial position

First quarter 2024 earnings released: EPS: ₹0.32 (vs ₹0.27 in 1Q 2023)

The Returns On Capital At MedPlus Health Services (NSE:MEDPLUS) Don't Inspire Confidence

MedPlus Health Services Limited to Report Q1, 2024 Results on Aug 01, 2023

Why Investors Shouldn't Be Surprised By MedPlus Health Services Limited's (NSE:MEDPLUS) P/S

Price target increased by 11% to ₹894

Full year 2023 earnings released: EPS: ₹4.17 (vs ₹8.55 in FY 2022)

MedPlus Health Services Limited to Report Q4, 2023 Results on May 25, 2023

A Look At The Fair Value Of MedPlus Health Services Limited (NSE:MEDPLUS)

Now 21% undervalued

MedPlus Health Services (NSE:MEDPLUS) Could Be Struggling To Allocate Capital

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

MedPlus Health Services Limited to Report Q3, 2023 Results on Feb 03, 2023

Consensus forecasts updated

Second quarter 2023 earnings released: EPS: ₹0.55 (vs ₹1.85 in 2Q 2022)

High number of new and inexperienced directors

Second quarter 2023 earnings released: EPS: ₹0.55 (vs ₹1.85 in 2Q 2022)

MedPlus Health Services Limited Appoints Sujit Kumar Mahato, as Chief Financial Officer

MedPlus Health Services Limited to Report Q2, 2023 Results on Nov 11, 2022

MedPlus Health Services Limited, Annual General Meeting, Sep 26, 2022

Consensus EPS estimates fall by 45%

First quarter 2023 earnings released: EPS: ₹0.27 (vs ₹3.08 in 1Q 2022)

MedPlus Health Services Limited to Report Q1, 2023 Results on Aug 12, 2022

₹1,177: That's What Analysts Think MedPlus Health Services Limited (NSE:MEDPLUS) Is Worth After Its Latest Results

Full year 2022 earnings: Revenues and EPS in line with analyst expectations

MedPlus Health Services Limited to Report Q4, 2022 Results on May 30, 2022

High number of new and inexperienced directors

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

MedPlus Health Services Limited to Report Q3, 2022 Results on Feb 14, 2022

Non-Executive Independent Director recently bought ₹5.5m worth of stock

High number of new and inexperienced directors

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Sağlıklı şirketleri keşfedin